Genmab A/S (GMAB)
34.40
+0.25
(+0.73%)
USD |
NASDAQ |
Sep 16, 16:00
34.38
-0.02
(-0.06%)
After-Hours: 20:00
Genmab Total Return Level : 34.40 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 34.40 |
| September 15, 2026 | 34.15 |
| September 14, 2026 | 32.65 |
| September 11, 2026 | 32.47 |
| September 10, 2026 | 32.23 |
| September 09, 2026 | 33.04 |
| September 08, 2026 | 33.53 |
| September 04, 2026 | 33.60 |
| September 03, 2026 | 34.41 |
| September 02, 2026 | 34.22 |
| September 01, 2026 | 33.29 |
| August 31, 2026 | 33.16 |
| August 28, 2026 | 33.23 |
| August 27, 2026 | 34.10 |
| August 26, 2026 | 33.75 |
| August 25, 2026 | 34.36 |
| August 24, 2026 | 33.02 |
| August 21, 2026 | 33.45 |
| August 20, 2026 | 33.41 |
| August 19, 2026 | 34.11 |
| August 18, 2026 | 32.96 |
| August 17, 2026 | 32.84 |
| August 14, 2026 | 31.94 |
| August 13, 2026 | 31.34 |
| August 12, 2026 | 31.42 |
| Date | Value |
|---|---|
| August 11, 2026 | 30.85 |
| August 10, 2026 | 30.87 |
| August 07, 2026 | 31.25 |
| August 06, 2026 | 29.83 |
| August 05, 2026 | 29.26 |
| August 04, 2026 | 29.02 |
| August 03, 2026 | 28.68 |
| July 31, 2026 | 28.87 |
| July 30, 2026 | 28.64 |
| July 29, 2026 | 28.52 |
| July 28, 2026 | 29.00 |
| July 27, 2026 | 28.80 |
| July 24, 2026 | 28.87 |
| July 23, 2026 | 29.17 |
| July 22, 2026 | 28.85 |
| July 21, 2026 | 28.36 |
| July 20, 2026 | 27.91 |
| July 17, 2026 | 28.72 |
| July 16, 2026 | 28.98 |
| July 15, 2026 | 29.08 |
| July 14, 2026 | 28.73 |
| July 13, 2026 | 28.80 |
| July 10, 2026 | 29.00 |
| July 09, 2026 | 29.78 |
| July 08, 2026 | 29.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 452.17 |
| Ascendis Pharma A/S | 247.69 |
| Zealand Pharma A/S | 43.00 |
| Bavarian Nordic A/S | 10.29 |
| Evaxion AS | 3.03 |